NHERF1 and colorectal carcinoma: Using CRC cells harboring different Wnt/β-catenin pathway mutations and low-NHERF1-levels at baseline, we show that genetic or pharmacological knockdown of β-catenin is sufficient to increase NHERF1 as a major driver of a cytoprotective autophagic response.